Advanced Microsphere and Hydrogel Platforms for Precision Interventional Therapy of Hepatocellular Carcinoma
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202502861 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Yanhui Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiamen Medical College, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Fujian Eng…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hydrogels, Microspheres. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 117 Literaturangaben. Gefördert von: Major State Basic Research Development Program of China, National Natural Science Foundation of China, Xiamen Medical Research Fund.
Abstract (Originalsprache)
Interventional management of hepatocellular carcinoma (HCC) remains hindered by profound tumor heterogeneity and an immunosuppressive microenvironment. While transarterial chemoembolization (TACE) constitutes the current standard of care, its therapeutic efficacy is compromised by burst drug release, incomplete vascular occlusion, and systemic toxicity. Emerging advanced biomaterial platforms—microspheres and hydrogels—are redefining this paradigm by enabling precise spatial and temporal control over embolization and drug delivery. Microspheres provide hierarchical vascular occlusion and sustained release through tunable size and mechanical properties, addressing the limitations of conventional lipiodol formulations. Hydrogels offer exceptional injectability, high payload capacity, and conformal filling of irregular cavities, thereby facilitating controlled intratumoral release and microenvironment modulation. Beyond embolization, these systems integrate seamlessly with multimodal therapies—including magnetic hyperthermia, radiotherapy, and immunotherapy—delivering synergistic “embolization–therapy–diagnosis” functionality. Incorporation of stimuli‐responsive motifs, imaging agents, and immunomodulators further enables localized ablation, reversal of immunosuppression, and induction of systemic antitumor immunity to suppress metastasis and recurrence. Despite encouraging preclinical outcomes, clinical translation faces challenges in biocompatibility, scalable fabrication, and standardized evaluation. This review highlights design strategies for next‐generation embolic materials that integrate precision embolization, multimodal imaging, and immune reprogramming, thereby advancing interventional HCC therapy toward intelligent and personalized solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Xiamen Medical College, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Fujian Engineering Research Center of Molecular Theranostic Technology, School o…
ORCID-Profile: Gang Liu
Förderung
- Major State Basic Research Development Program of China
- National Natural Science Foundation of China
- Xiamen Medical Research Fund
- Shenzhen Medical Research Fund
- Clinical Research Center for Radiation
- Therapy Open Project Innovation Team Project of Sichuan Province
- Program for New Century Excellent Talents in University, China
Zitieren
APA
Wang, Y., Zeng, Y., & Liu, G. (2025). Advanced Microsphere and Hydrogel Platforms for Precision Interventional Therapy of Hepatocellular Carcinoma. Chemistry – A European Journal. https://doi.org/10.1002/chem.202502861
Vancouver
Wang Y, Zeng Y, Liu G. Advanced Microsphere and Hydrogel Platforms for Precision Interventional Therapy of Hepatocellular Carcinoma. Chemistry – A European Journal. 2025. doi:10.1002/chem.202502861
BibTeX
@article{Wang2025,
author = {Wang, Yanhui and Zeng, Yun and Liu, Gang},
title = {Advanced Microsphere and Hydrogel Platforms for Precision Interventional Therapy of Hepatocellular Carcinoma},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202502861}
}
EUVIMED